Transcatheter aortic valve replacement with CoreValve.
The treatment of aortic stenosis in high-risk surgical patients is now possible by transcatheter aortic valve replacement. The CoreValve is a new transcatheter valve with a unique design expanding its application in patients with aortic stenosis. The CoreValve is just completing clinical trial in the United States and not yet available for commercial use in the United States but is widely used in Europe.
Division of Cardiovascular Medicine, Keck School of Medicine, Los Angeles, CA 90033, USA. raymatth@usc.edu
Ray V
RV
Matthews
David M
DM
Shavelle
D000369:Aged, 80 and over; D001024:Aortic Valve Stenosis / Q000628:therapy*; D063126:Balloon Valvuloplasty / Q000379:methods*; D006328:Cardiac Catheterization / Q000379:methods; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000295:instrumentation* / Q000379:methods; D006801:Humans; D015337:Multicenter Studies as Topic; D011474:Prosthesis Design; D016032:Randomized Controlled Trials as Topic; D012042:Registries; D015607:Stents
Aortic stenosis; CoreValve; Heart valve; Percutaneous; TAVI; TAVR